SCHEMBL733323

SCHEMBL733323

CC(=O)Oc1cc(C(=O)O)cc2c1ccn2C1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 6/20 0.46
TSHR P16473 4/20 0.46
GAA P10253 2/20 0.46
RAB9A P51151 1/20 0.46
HPGD P15428 3/20 0.38
PKM P14618 2/20 0.38
USP2 O75604 2/20 0.38
HTT P42858 2/20 0.38
TTR P02766 2/20 0.38
MEN1 O00255 1/20 0.38
ABCC4 O15439 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HSP90AA1 P07900 1/20 0.38
CHRM2 P08172 1/20 0.38
HSP90AB1 P08238 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308481 0.87 CA12 (0.44) TSHRRAB9APKMHTTTTR
SCHEMBL308824 0.85 ALDH1A1 (0.38) KDM4EALDH1A1RAB9AUSP2HTT
SCHEMBL12761507 0.81 AKT1 (0.36) KDM4EALDH1A1TSHRGAAHPGD
SCHEMBL309329 0.80 HSD17B10 (0.36) GAAHPGDLMNASMN1; SMN2HSD17B10
SCHEMBL1501711 0.78 KDM4E (0.39) KDM4EALDH1A1GAAHPGDLMNA
SCHEMBL12833013 0.76 TNF (0.32) ALDH1A1PTGS1
SCHEMBL308949 0.72 HSD17B2 (0.48) KDM4EALDH1A1GAARAB9AUSP2
SCHEMBL309993 0.69 TSHR (0.38) ALDH1A1TSHRGAARAB9AHPGD
SCHEMBL731446 0.69 SMN1; SMN2 (0.37) KDM4EALDH1A1GAARAB9AHPGD
SCHEMBL742242 0.68 GPR35 (0.36) ALDH1A1GAAMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 KDM4E 3445/4885ALDH1A1 113/4885TSHR 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.